Robinhood stock slips after CEO’s sale filing; HOOD in focus ahead of Feb. 10 earnings
7 January 2026
1 min read

Robinhood stock slips after CEO’s sale filing; HOOD in focus ahead of Feb. 10 earnings

New York, Jan 7, 2026, 12:41 EST — Regular session

  • Robinhood shares were down about 2% in midday trading, tracking a softer tape for brokerage and crypto-linked stocks.
  • A filing showed CEO Vladimir Tenev plans to sell up to 375,000 shares, worth about $43 million.
  • Investors are looking ahead to Robinhood’s Feb. 10 quarterly results after a sharp 2025 run.

Robinhood Markets Inc (HOOD.O) shares fell 2.1% to $119.14 in midday trading on Wednesday after a filing showed Chief Executive Vladimir Tenev planned to sell up to 375,000 shares, worth about $43.2 million, through Morgan Stanley Smith Barney. The stock traded between $117.61 and $121.95. 1

The move matters because Robinhood has become a crowded trade after a strong run: its shares nearly tripled in 2025, Reuters Breakingviews reported, putting more weight on insider transactions and small shifts in expectations. 2

Form 144 is a notice insiders file ahead of a proposed sale of restricted or “control” stock. The filing referenced a Rule 10b5-1 plan, a pre-arranged trading plan that can schedule sales in advance.

Goldman Sachs analyst James Yaro lowered his price target on Robinhood to $161 from $164 and kept a buy rating, StreetInsider reported. 3

Crypto-linked and brokerage shares were broadly lower as bitcoin eased about 0.7% to $91,488. Coinbase fell 1.7%, while Interactive Brokers and Charles Schwab were also down in midday trade.

On the chart, traders have been watching the $117 area near the stock’s 200-day moving average, with the $125 zone near the 50-day average acting as a near-term hurdle, MarketBeat data showed. The same data put the average analyst price target at about $136.80. 4

Robinhood is due to report fourth-quarter and full-year 2025 results on Feb. 10 after the close, and it plans a video call with CEO Vlad Tenev and incoming CFO Shiv Verma at 5 p.m. ET. The company said its Q&A platform for shareholders opens Feb. 3. 5

But the business still swings with retail trading appetites, especially in crypto and options. A calmer market can sap transaction revenue, and any fresh regulatory heat around higher-risk products could hit sentiment quickly.

For now, investors will watch whether the stock holds above that longer-term support area and whether the proposed sales turn into actual selling. The next scheduled catalyst is the Feb. 10 earnings report.

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale
Previous Story

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips
Next Story

China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips

Go toTop